BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 12723962)

  • 1. Biaryl analogues of conformationally constrained tricyclic tropanes as potent and selective norepinephrine reuptake inhibitors: synthesis and evaluation of their uptake inhibition at monoamine transporter sites.
    Zhou J; Zhang A; Kläss T; Johnson KM; Wang CZ; Ye YP; Kozikowski AP
    J Med Chem; 2003 May; 46(10):1997-2007. PubMed ID: 12723962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Further structural exploration of trisubstituted asymmetric pyran derivatives (2S,4R,5R)-2-benzhydryl-5-benzylamino-tetrahydropyran-4-ol and their corresponding disubstituted (3S,6S) pyran derivatives: a proposed pharmacophore model for high-affinity interaction with the dopamine, serotonin, and norepinephrine transporters.
    Zhang S; Fernandez F; Hazeldine S; Deschamps J; Zhen J; Reith ME; Dutta AK
    J Med Chem; 2006 Jul; 49(14):4239-47. PubMed ID: 16821783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and monoamine uptake inhibition of conformationally constrained 2beta-carbomethoxy-3beta-phenyl tropanes.
    Riss PJ; Hummerich R; Schloss P
    Org Biomol Chem; 2009 Jul; 7(13):2688-98. PubMed ID: 19532984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-activity relationship studies on a novel series of (S)-2beta-substituted 3alpha-[bis(4-fluoro- or 4-chlorophenyl)methoxy]tropane analogues for in vivo investigation.
    Zou MF; Cao J; Kopajtic T; Desai RI; Katz JL; Newman AH
    J Med Chem; 2006 Oct; 49(21):6391-9. PubMed ID: 17034144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An extended study of dimeric phenyl tropanes.
    Nielsen S; Pedersen CM; Hansen SG; Petersen MD; Sinning S; Wiborg O; Jensen HH; Bols M
    Bioorg Med Chem; 2009 Jul; 17(14):4900-9. PubMed ID: 19560930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and monoamine transporter binding properties of 2,3-cyclo analogues of 3beta-(4'-aminophenyl)-2beta-tropanemethanol.
    Carroll FI; Blough BE; Huang X; Nie Z; Mascarella SW; Deschamps J; Navarro HA
    J Med Chem; 2006 Jul; 49(15):4589-94. PubMed ID: 16854064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and monoamine transporter affinity of front bridged tricyclic 3beta-(4'-halo or 4'-methyl)phenyltropanes bearing methylene or carbomethoxymethylene on the bridge to the 2beta-position.
    Zeng F; Jarkas N; Owens MJ; Kilts CD; Nemeroff CB; Goodman MM
    Bioorg Med Chem Lett; 2006 Sep; 16(17):4661-3. PubMed ID: 16784855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1-(Indolin-1-yl)-1-phenyl-3-propan-2-olamines as potent and selective norepinephrine reuptake inhibitors.
    Vu AT; Cohn ST; Zhang P; Kim CY; Mahaney PE; Bray JA; Johnston GH; Koury EJ; Cosmi SA; Deecher DC; Smith VA; Harrison JE; Leventhal L; Whiteside GT; Kennedy JD; Trybulski EJ
    J Med Chem; 2010 Mar; 53(5):2051-62. PubMed ID: 20131864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery and pharmacological characterization of aryl piperazine and piperidine ethers as dual acting norepinephrine reuptake inhibitors and 5-HT1A partial agonists.
    Gray DL; Xu W; Campbell BM; Dounay AB; Barta N; Boroski S; Denny L; Evans L; Stratman N; Probert A
    Bioorg Med Chem Lett; 2009 Dec; 19(23):6604-7. PubMed ID: 19854053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 1- or 3-(3-Amino-2-hydroxy-1-phenyl propyl)-1,3-dihydro-2H-benzimidazol-2-ones: potent, selective, and orally efficacious norepinephrine reuptake inhibitors.
    Zhang P; Terefenko EA; Bray J; Deecher D; Fensome A; Harrison J; Kim C; Koury E; Mark L; McComas CC; Mugford CA; Trybulski EJ; Vu AT; Whiteside GT; Mahaney PE
    J Med Chem; 2009 Sep; 52(18):5703-11. PubMed ID: 19722525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In-vitro and in-vivo characterization of JNJ-7925476, a novel triple monoamine uptake inhibitor.
    Aluisio L; Lord B; Barbier AJ; Fraser IC; Wilson SJ; Boggs J; Dvorak LK; Letavic MA; Maryanoff BE; Carruthers NI; Bonaventure P; Lovenberg TW
    Eur J Pharmacol; 2008 Jun; 587(1-3):141-6. PubMed ID: 18499098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis, and preliminary SAR study of 3- and 6-side-chain-extended tetrahydro-pyran analogues of cis- and trans-(6-benzhydryl-tetrahydropyran-3-yl)-benzylamine.
    Zhang S; Zhen J; Reith ME; Dutta AK
    Bioorg Med Chem; 2006 Jun; 14(11):3953-66. PubMed ID: 16481172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 6-(3,4-dichlorophenyl)-1-[(methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: a new potent and selective triple reuptake inhibitor.
    Micheli F; Cavanni P; Andreotti D; Arban R; Benedetti R; Bertani B; Bettati M; Bettelini L; Bonanomi G; Braggio S; Carletti R; Checchia A; Corsi M; Fazzolari E; Fontana S; Marchioro C; Merlo-Pich E; Negri M; Oliosi B; Ratti E; Read KD; Roscic M; Sartori I; Spada S; Tedesco G; Tarsi L; Terreni S; Visentini F; Zocchi A; Zonzini L; Di Fabio R
    J Med Chem; 2010 Jul; 53(13):4989-5001. PubMed ID: 20527970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and in vivo evaluation of fluorine-18 and iodine-123 labeled 2beta-carbo(2-fluoroethoxy)-3beta-(4'-((Z)-2-iodoethenyl)phenyl)nortropane as a candidate serotonin transporter imaging agent.
    Plisson C; Stehouwer JS; Voll RJ; Howell L; Votaw JR; Owens MJ; Goodman MM
    J Med Chem; 2007 Sep; 50(19):4553-60. PubMed ID: 17705359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rigid Adenine Nucleoside Derivatives as Novel Modulators of the Human Sodium Symporters for Dopamine and Norepinephrine.
    Janowsky A; Tosh DK; Eshleman AJ; Jacobson KA
    J Pharmacol Exp Ther; 2016 Apr; 357(1):24-35. PubMed ID: 26813929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Caulis Sinomenii extracts activate DA/NE transporter and inhibit 5HT transporter.
    Zhao G; Bi C; Qin GW; Guo LH
    Exp Biol Med (Maywood); 2009 Aug; 234(8):976-85. PubMed ID: 19491370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2-Aminoindan and its ring-substituted derivatives interact with plasma membrane monoamine transporters and α
    Halberstadt AL; Brandt SD; Walther D; Baumann MH
    Psychopharmacology (Berl); 2019 Mar; 236(3):989-999. PubMed ID: 30904940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, monoamine transporter binding, properties, and functional monoamine uptake activity of 3beta-[4-methylphenyl and 4-chlorophenyl]-2 beta-[5-(substituted phenyl)thiazol-2-yl]tropanes.
    Gong PK; Blough BE; Brieaddy LE; Huang X; Kuhar MJ; Navarro HA; Carroll FI
    J Med Chem; 2007 Jul; 50(15):3686-95. PubMed ID: 17602602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preclinical pharmacology of TP1, a novel potent triple reuptake inhibitor with antidepressant properties.
    Tian JW; Jiang WL; Zhong Y; Meng Q; Gai Y; Zhu HB; Hou J; Xing Y; Li YX
    Neuroscience; 2011 Nov; 196():124-30. PubMed ID: 21925241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The extracts of Fructus Akebiae, a preparation containing 90% of the active ingredient hederagenin: serotonin, norepinephrine and dopamine reuptake inhibitor.
    Jin ZL; Gao N; Zhou D; Chi MG; Yang XM; Xu JP
    Pharmacol Biochem Behav; 2012 Jan; 100(3):431-9. PubMed ID: 22005599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.